OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 85 filers reported holding OVID THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 6.38 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,714 | -6.3% | 4,613 | -20.0% | 0.00% | – |
| Q2 2023 | $18,903 | -10.0% | 5,763 | +10.8% | 0.00% | – |
| Q1 2021 | $21,000 | -65.6% | 5,199 | -80.4% | 0.00% | – |
| Q4 2020 | $61,000 | +103.3% | 26,521 | +410.1% | 0.00% | – |
| Q3 2020 | $30,000 | -42.3% | 5,199 | -26.4% | 0.00% | – |
| Q2 2020 | $52,000 | +1200.0% | 7,062 | +229.2% | 0.00% | – |
| Q2 2019 | $4,000 | 0.0% | 2,145 | 0.0% | 0.00% | – |
| Q1 2019 | $4,000 | -20.0% | 2,145 | 0.0% | 0.00% | – |
| Q4 2018 | $5,000 | -58.3% | 2,145 | 0.0% | 0.00% | – |
| Q3 2018 | $12,000 | -29.4% | 2,145 | 0.0% | 0.00% | – |
| Q2 2018 | $17,000 | +13.3% | 2,145 | 0.0% | 0.00% | – |
| Q1 2018 | $15,000 | +36.4% | 2,145 | +95.4% | 0.00% | – |
| Q4 2017 | $11,000 | +10.0% | 1,098 | 0.0% | 0.00% | – |
| Q3 2017 | $10,000 | -9.1% | 1,098 | 0.0% | 0.00% | – |
| Q2 2017 | $11,000 | – | 1,098 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 4,006,185 | $12,860,000 | 5.90% |
| GLOBEFLEX CAPITAL L P | 2,794,834 | $8,972,000 | 0.92% |
| BVF INC/IL | 6,631,051 | $21,286,000 | 0.77% |
| EcoR1 Capital, LLC | 6,082,200 | $19,524,000 | 0.62% |
| CHI Advisors LLC | 400,000 | $1,284,000 | 0.43% |
| Ikarian Capital, LLC | 705,082 | $2,264,000 | 0.34% |
| Artal Group S.A. | 2,500,000 | $8,025,000 | 0.22% |
| DCF Advisers, LLC | 141,701 | $455,000 | 0.18% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 766,901 | $2,462,000 | 0.07% |
| ACADIAN ASSET MANAGEMENT LLC | 2,040,084 | $6,543,000 | 0.02% |